ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2446

Nailfold Videocapillaroscopy Findings in Patients with Limited Cutaneous versus Diffuse Cutaneous Systemic Sclerosis: The First Detailed Retrospective Study

Ana Margarida Correia1, Rosanna Campitiello2, Emanuele Gotelli3, Carmen Pizzorni4, Alberto Sulli5, vanessa smith6 and Maurizio Cutolo3, 1Hospital de Braga, Unidade Local de Saúde de Braga, Braga, Portugal, 2Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS Ospedale Policlinico San Martino, Genoa, Italy, Genova, Liguria, Italy, 3Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS Ospedale Policlinico San Martino, Genoa, Italy, Genova, Italy, 4Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS Ospedale Policlinico San Martino, Genoa, Italy, Genoa, Italy, 5Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Genova, Italy, 6Ghent University Hospital, Gent, Belgium

Meeting: ACR Convergence 2024

Keywords: Angiogenesis, Raynaud's phenomenon, skin, Systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Systemic Sclerosis & Related Disorders – Clinical Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Systemic sclerosis (SSc) is a connective tissue disease characterized by microvascular damage, immune system activation and fibrosis. Clinical phenotypes are defined according to skin fibrosis – limited (lSSc) and diffuse (dSSc) SSc. Few studies suggested a higher prevalence of “late” scleroderma pattern (LSP) and capillary loss on nailfold videocapillaroscopy (NVC) in dSSc1-3. However, the association of the detailed NVC findings and the extent of skin fibrosis is not yet clearly stablished.
The aim of this study was to compare the NVC findings between lSSc and dSSc patients (pts).

Methods: We enrolled 157 pts at the Division of Rheumatology of the University of Genova; 127 SSc pts and 30 primary Raynaud phenomenon (pRP) pts.  The NVC patterns and the absolute number of capillaries (1 linear mm) of the first NVC performed were accessed. The scores A (early NVC changes: capillary dilations, microhemorrhages and giant capillaries) and B (advanced NVC changes: capillary density, altered microvascular architecture and abnormal capillary shapes (angiogenesis)) were also calculated in the NVC of SSc pts. These scores represent semiquantitative assessments ranking from 0 to 3 according to the extent of NVC parameters (0: no changes; 1: ≤33% changes; 2: 33-66% changes; 3: ≥66% changes)4.

Results: The absolute number of capillaries showed a statistically significant difference between pts with pRP, lSSc and dSSc (F(2,154)=50.18,p< 0.001) (Image1). The post-hoc analysis demonstrated that the absolute capillary number was significantly higher in pRP pts (8.87±0.78,p< 0.001) than in SSc pts; although capillary loss was present in both lSSc and dSSc, it was significantly higher in pts with dSSc (4.89±1.53,p< 0.001) compared to lSSc (6.18±1.75,p< 0.001). Additionally, a significantly higher B score was observed in dSSc (t(125)=-3.95,p< 0.001), with a lower capillary density (H(1)=12.01,p< 0.001), altered capillary architecture (H(1)=13.96,p< 0.001) and presence of abnormal shapes (angiogenesis) (H(1)=8.00,p=0.005) (Table1). Furthermore, statistically significant associations were established between LSP and dSSc (c2(1,126)=10.45,p=0.004), as well as between “early” scleroderma pattern (ESP) and lSSc (c2(1,126)=6.56,p=0.010). No association was found regarding A score and the extent of skin fibrosis in SSc.

Conclusion: Present study highlights the importance of NVC in distinguishing microvascular damage between lSSc and dSSc. Both clinical phenotypes are associated with capillary loss, particularly in dSSc, despite the greater use of immunosuppressants. Moreover, higher B scores seem correlated with dSSc and both capillary density and abnormal shapes (angiogenesis). This finding was confirmed by the association of LSP with dSSc. No differences regarding giants were found between lSSc and dSSc. This can be explained by the prevalence of ESP (presence of few giants) in lSSc and of LSP (absence of giants) in dSSc.

REFERENCES:

1Cutolo M et al. Nat Rev Rheumatol 2021

2Ingegnoli F et al. Microvasc Res. 2013

3Sato LT et al. Acta Reumatol Port. 2009

4Sulli A et al. Ann Rheum Dis 2008

Supporting image 1

Table 1: Descriptive and comparative statistics of the demographic, clinical, laboratorial and capillaroscopic variables in lSSc and dSSc; p-value <0.05 was considered significant.

Supporting image 2

Image 1: Absolute capillary number (1 linear mm) by pRP and SSc clinical phenotypes.


Disclosures: A. Correia: None; R. Campitiello: None; E. Gotelli: None; C. Pizzorni: None; A. Sulli: AbbVie/Abbott, 5, Baldacci, 2, 5, UCB, 5; v. smith: Argenx, 2, BKC Moving Media Makers, 6, Boehringer-Ingelheim, 2, 5, 6, Janssen, 2, 5, 6, WebMDD Global LLC, 2; M. Cutolo: AbbVie/Abbott, 5, Amgen, 5, Balcacci, 2, 5, Boehringer-Ingelheim, 2, 5, Bristol-Myers Squibb(BMS), 2, 5, UCB, 5.

To cite this abstract in AMA style:

Correia A, Campitiello R, Gotelli E, Pizzorni C, Sulli A, smith v, Cutolo M. Nailfold Videocapillaroscopy Findings in Patients with Limited Cutaneous versus Diffuse Cutaneous Systemic Sclerosis: The First Detailed Retrospective Study [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/nailfold-videocapillaroscopy-findings-in-patients-with-limited-cutaneous-versus-diffuse-cutaneous-systemic-sclerosis-the-first-detailed-retrospective-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/nailfold-videocapillaroscopy-findings-in-patients-with-limited-cutaneous-versus-diffuse-cutaneous-systemic-sclerosis-the-first-detailed-retrospective-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology